Skip to main content
. 2017 May 15;9:17–25. doi: 10.2147/HMER.S113681

Table 5.

Outcome of therapy with different DAA regimens in Egypt in 2015–2016

SOF–PEG–RBV 12 weeks SOF–RBV 24 weeks SOF–SMV 12 weeks SOF–DCV 12 weeks SOF–DCV–RBV 12 weeks
Number 13,260 7,958 6,160 10,120 8,258
SVR12, n (%) 11,907 (90) 6,040 (76) 5,739 (93) 9,653 (95) 7,820 (95)
Nonresponse, n (%) 904 (7) 934 (12) 292 (5) 359 (3.5) 349 (4)
Relapse, n (%) 450 (3) 984 (12) 129 (2) 108 (1) 89 (1)

Note: El Raziky et al and Doss et al.45,46

Abbreviations: DAA, direct-acting antivirals; SOF, sofosbuvir; PEG, pegylated interferon; RBV, ribavirin; SMV, simeprevir; DCV, daclatasvir; SVR, sustained virologic response.